Cargando…

Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors

BACKGROUND: Hypersensitivity pneumonitis (HP) is the third, according to frequency, interstitial lung disease, with the estimated incidence rate of 1–2/100,000. In HP patients, the extensive inflammatory lesions encompassing both small airways and lung parenchyma, as well as subsequent development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dybowska, Małgorzata, Barańska, Inga, Franczuk, Monika, Skoczylas, Agnieszka, Szturmowicz, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339783/
https://www.ncbi.nlm.nih.gov/pubmed/34422329
http://dx.doi.org/10.21037/jtd-21-130
_version_ 1783733664769638400
author Dybowska, Małgorzata
Barańska, Inga
Franczuk, Monika
Skoczylas, Agnieszka
Szturmowicz, Monika
author_facet Dybowska, Małgorzata
Barańska, Inga
Franczuk, Monika
Skoczylas, Agnieszka
Szturmowicz, Monika
author_sort Dybowska, Małgorzata
collection PubMed
description BACKGROUND: Hypersensitivity pneumonitis (HP) is the third, according to frequency, interstitial lung disease, with the estimated incidence rate of 1–2/100,000. In HP patients, the extensive inflammatory lesions encompassing both small airways and lung parenchyma, as well as subsequent development of lung fibrosis, may result in respiratory insufficiency and secondary pulmonary hypertension (PH). The aim of the present retrospective study was to assess the prevalence of echocardiographic signs of PH and its’ clinical predictors, in newly recognized HP patients. METHODS: Consecutive HP patients, recognized in single pulmonary unit between 2005 and 2017, in whom echocardiography was performed at diagnosis, entered the present study. HP diagnosis was verified in every patient according to current diagnostic recommendations. The results of high resolution computed tomography of the chest (HRCT) were re-evaluated by two independent radiologists, blinded to clinical data. Echocardiographic signs of PH were defined as pulmonary artery systolic pressure (PASP) exceeding 36 mmHg. Regression analysis was applied to calculate PH risk, and receiver operator characteristic curves (ROC) were plotted to investigate diagnostic utility of various parameters in PH prediction. RESULTS: PASP exceeding 36 mmHg was noted in 26 out of 70 patients (37%)—with equal frequency among patients with fibrotic and non-fibrotic HP. Significant predictors of PH on echocardiography were: partial oxygen tension in arterialized capillary blood (PaO2) <69 mmHg, lung transfer capacity for carbon monoxide (TLCO) <42% of predicted, six minutes walking test (6MWT) distance <455 meters, and 6MWT desaturation rate >8%. In case of TLCO <42% of predicted, probability of PH on echocardiography was increased by five-fold, in case of 6MWT desaturation rate >8%—by four fold. CONCLUSIONS: The best predictors of PASP >36 mmHg on echocardiography in HP patients at diagnosis were: TLCO <42% and 6MWT desaturation rate >8%. Neither the presence of lung fibrosis on HRCT, nor the duration of the disease or patients age, were helpful in PH prediction.
format Online
Article
Text
id pubmed-8339783
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-83397832021-08-20 Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors Dybowska, Małgorzata Barańska, Inga Franczuk, Monika Skoczylas, Agnieszka Szturmowicz, Monika J Thorac Dis Original Article BACKGROUND: Hypersensitivity pneumonitis (HP) is the third, according to frequency, interstitial lung disease, with the estimated incidence rate of 1–2/100,000. In HP patients, the extensive inflammatory lesions encompassing both small airways and lung parenchyma, as well as subsequent development of lung fibrosis, may result in respiratory insufficiency and secondary pulmonary hypertension (PH). The aim of the present retrospective study was to assess the prevalence of echocardiographic signs of PH and its’ clinical predictors, in newly recognized HP patients. METHODS: Consecutive HP patients, recognized in single pulmonary unit between 2005 and 2017, in whom echocardiography was performed at diagnosis, entered the present study. HP diagnosis was verified in every patient according to current diagnostic recommendations. The results of high resolution computed tomography of the chest (HRCT) were re-evaluated by two independent radiologists, blinded to clinical data. Echocardiographic signs of PH were defined as pulmonary artery systolic pressure (PASP) exceeding 36 mmHg. Regression analysis was applied to calculate PH risk, and receiver operator characteristic curves (ROC) were plotted to investigate diagnostic utility of various parameters in PH prediction. RESULTS: PASP exceeding 36 mmHg was noted in 26 out of 70 patients (37%)—with equal frequency among patients with fibrotic and non-fibrotic HP. Significant predictors of PH on echocardiography were: partial oxygen tension in arterialized capillary blood (PaO2) <69 mmHg, lung transfer capacity for carbon monoxide (TLCO) <42% of predicted, six minutes walking test (6MWT) distance <455 meters, and 6MWT desaturation rate >8%. In case of TLCO <42% of predicted, probability of PH on echocardiography was increased by five-fold, in case of 6MWT desaturation rate >8%—by four fold. CONCLUSIONS: The best predictors of PASP >36 mmHg on echocardiography in HP patients at diagnosis were: TLCO <42% and 6MWT desaturation rate >8%. Neither the presence of lung fibrosis on HRCT, nor the duration of the disease or patients age, were helpful in PH prediction. AME Publishing Company 2021-07 /pmc/articles/PMC8339783/ /pubmed/34422329 http://dx.doi.org/10.21037/jtd-21-130 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Dybowska, Małgorzata
Barańska, Inga
Franczuk, Monika
Skoczylas, Agnieszka
Szturmowicz, Monika
Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors
title Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors
title_full Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors
title_fullStr Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors
title_full_unstemmed Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors
title_short Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors
title_sort echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339783/
https://www.ncbi.nlm.nih.gov/pubmed/34422329
http://dx.doi.org/10.21037/jtd-21-130
work_keys_str_mv AT dybowskamałgorzata echocardiographicsignsofpulmonaryhypertensioninpatientswithnewlyrecognizedhypersensitivitypneumonitisprevalenceandclinicalpredictors
AT baranskainga echocardiographicsignsofpulmonaryhypertensioninpatientswithnewlyrecognizedhypersensitivitypneumonitisprevalenceandclinicalpredictors
AT franczukmonika echocardiographicsignsofpulmonaryhypertensioninpatientswithnewlyrecognizedhypersensitivitypneumonitisprevalenceandclinicalpredictors
AT skoczylasagnieszka echocardiographicsignsofpulmonaryhypertensioninpatientswithnewlyrecognizedhypersensitivitypneumonitisprevalenceandclinicalpredictors
AT szturmowiczmonika echocardiographicsignsofpulmonaryhypertensioninpatientswithnewlyrecognizedhypersensitivitypneumonitisprevalenceandclinicalpredictors